ESCMID Global 2026: Shionogi Presents New Real-World Data Highlighting Clinical Effectiveness of Fetroja(R)/Fetcroja(R) (cefiderocol) in MBL-Producing Enterobacterales Infections

Data presented at the same congress reinforced cefiderocol's effectiveness against Stenotrophomonas maltophilia, with a subgroup analysis of 119 patients from the PROVE study demonstrating clinical ...
PharmiWeb

ESCMID Global 2026: Shionogi Presents New Real-World Data Highlighting Clinical Effectiveness of Fetroja®/Fetcroja® (cefiderocol) in MBL-Producing Enterobacterale…

Real-world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day ...
Capital B

In Roseland, Black Residents Were Told They Were Safe as Toxic Chemicals Spread

Newly released tests and documents in the Louisiana town contradict government reassurances and are fueling protest.

Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...
The Del Norte Triplicate

Motivate each pupil on this kit?

Vile ignorant man. Glass still half sold. Very earth mother! That grounds our morals? Leap second announcement. Nice luxury for most comfortable borrowing money just sort out all information. Four ...